Cargando…

Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis

Changes in metabolism are common phenomena in tumors. Glutamine (Gln) has been documented to play a critical role in tumor growth. In this study, we aimed to to explore the mechanisms through which bladder cancer cells utilize Gln to fulfill their biosynthetic needs during proliferation. In addition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Ningchuan, Liang, Ye, Chen, Yuanbin, Wang, Liping, Li, Dan, Liang, Zhijuan, Sun, Lijiang, Wang, Yonghua, Niu, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844601/ https://www.ncbi.nlm.nih.gov/pubmed/31661119 http://dx.doi.org/10.3892/ijmm.2019.4385

Ejemplares similares

The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ
por: Wang, Liping, et al.
Publicado: (2018)

Immunosuppression Induced by Glutamine Deprivation Occurs via Activating PD-L1 Transcription in Bladder Cancer
por: Wang, Liping, et al.
Publicado: (2021)

Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment
por: Ma, Guofeng, et al.
Publicado: (2022)

Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer
por: Liang, Ye, et al.
Publicado: (2020)

Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies
por: Ma, Guofeng, et al.
Publicado: (2021)

Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1‐driven acute lymphoblastic leukemia
por: Nguyen, Tra Ly, et al.
Publicado: (2021)

Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1
por: Zhang, Zhao, et al.
Publicado: (2023)

Latent KSHV Infected Endothelial Cells Are Glutamine Addicted and Require Glutaminolysis for Survival
por: Sanchez, Erica L., et al.
Publicado: (2015)

MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent
por: Wang, Tingting, et al.
Publicado: (2018)

Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression
por: Zhang, Zhilei, et al.
Publicado: (2023)

Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism
por: Cacace, Andrea, et al.
Publicado: (2016)

Glutamine and glutaminolysis are required for efficient replication of infectious spleen and kidney necrosis virus in Chinese perch brain cells
por: Fu, Xiaozhe, et al.
Publicado: (2016)

CircHMGCS1 Promotes Hepatoblastoma Cell Proliferation by Regulating the IGF Signaling Pathway and Glutaminolysis
por: Zhen, Ni, et al.
Publicado: (2019)

Bacillus Calmette–Guérin and anti-PD-L1 combination therapy boosts immune response against bladder cancer
por: Wang, Yonghua, et al.
Publicado: (2018)

Glutaminolysis gets the spotlight in cancer
por: Herranz, Daniel
Publicado: (2016)

USP24-GSDMB complex promotes bladder cancer proliferation via activation of the STAT3 pathway
por: He, Haiqing, et al.
Publicado: (2021)

Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
por: Yu, Yongbo, et al.
Publicado: (2021)

Correction: Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
por: Yu, Yongbo, et al.
Publicado: (2023)

Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer
por: Chen, Yuanbin, et al.
Publicado: (2021)

Glutaminolysis feeds mTORC1
por: Durán, Raúl V., et al.
Publicado: (2012)

Governing glutaminolysis by regulation of glutaminase succinylation
por: Ma, Qingxia, et al.
Publicado: (2021)

FAIM regulates autophagy through glutaminolysis in lung adenocarcinoma
por: Han, Tianyu, et al.
Publicado: (2021)

Glutaminolysis and peripheral CD4(+) T cell differentiation: from mechanism to intervention strategy
por: Liu, Tong, et al.
Publicado: (2023)

Metabolic Signaling Cascades Prompted by Glutaminolysis in Cancer
por: Shah, Raj, et al.
Publicado: (2020)

Epigenetic regulation of IPF fibroblast phenotype by glutaminolysis
por: Xiang, Zheyi, et al.
Publicado: (2022)

TRPM8 Inhibition Regulates the Proliferation, Migration and ROS Metabolism of Bladder Cancer Cells
por: Wang, Gang, et al.
Publicado: (2020)

Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer
por: Hwang, Yeseong, et al.
Publicado: (2023)

BAG3 promotes autophagy and glutaminolysis via stabilizing glutaminase
por: Zhao, Song, et al.
Publicado: (2019)

Myc-Foxo, a link between glutaminolysis and autophagy
por: Zola, Sheri, et al.
Publicado: (2012)

Non-Coding RNAs as Key Regulators of Glutaminolysis in Cancer
por: Ortiz-Pedraza, Yunuen, et al.
Publicado: (2020)

Preventing Glutaminolysis: A Potential Therapy for Pulmonary Fibrosis
por: Esguerra, Vincent, et al.
Publicado: (2019)

Effects of Ferroptosis on the Metabolome in Cardiac Cells: The Role of Glutaminolysis
por: Rodríguez-Graciani, Keishla M., et al.
Publicado: (2022)

Glutaminolysis and the Control of Neural Progenitors in Neocortical Development and Evolution
por: Gkini, Vasiliki, et al.
Publicado: (2022)

Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression
por: Du, Kuo, et al.
Publicado: (2019)

Glutaminolysis and CD4(+) T-cell metabolism in autoimmunity: From pathogenesis to therapy prospects
por: Feng, Xiaojin, et al.
Publicado: (2022)

Sirtuin5 contributes to colorectal carcinogenesis by enhancing glutaminolysis in a deglutarylation-dependent manner
por: Wang, Yun-Qian, et al.
Publicado: (2018)

Curcumin analog WZ26 induces ROS and cell death via inhibition of STAT3 in cholangiocarcinoma
por: Chen, Minxiao, et al.
Publicado: (2023)

Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer
por: Sun, Li, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5ovj2rc7ro1sbfi12n11g6fsli